Al-Hebshi Abdulqader
Pediatric Hematology Oncology, Prince Mohammed Bin Abdulaziz Hospital, Medina, SAU.
Pediatric Hematology Oncology, Ministry of National Guard Health Affairs, Medina, SAU.
Cureus. 2020 Nov 25;12(11):e11708. doi: 10.7759/cureus.11708.
Inherited platelet disorders (IPDs) are genetically heterogeneous rare disorders due to quantitative and/or qualitative abnormalities of the platelet. IPDs are often predisposed to significant medical complications. RAS guanyl-releasing protein-2 (RASGRP2) was recently identified as a gene affected in patients with platelet function defects and a bleeding complication. RASGRP2 codes for the protein CalDAG-GEFI RAS (guanyl-releasing protein-2), a guanine nucleotide exchange factor for small guanosine triphosphate(GTP)ase Rap1. We used Sanger sequencing to identify a novel function-disrupting homozygous mutation in RASGRP2 responsible for bleeding diathesis and platelet dysfunction in a patient.
遗传性血小板疾病(IPDs)是由于血小板数量和/或质量异常导致的遗传异质性罕见疾病。IPDs常易引发严重的医学并发症。RAS鸟苷释放蛋白2(RASGRP2)最近被确定为在血小板功能缺陷和出血并发症患者中受影响的基因。RASGRP2编码蛋白CalDAG-GEFI RAS(鸟苷释放蛋白2),一种小GTP酶Rap1的鸟嘌呤核苷酸交换因子。我们使用桑格测序法在一名患者中鉴定出RASGRP2中一个导致出血素质和血小板功能障碍的新型功能破坏纯合突变。